Cargando…

Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection

BACKGROUND: The impact of maternal severe acute respiratory syndrome coronavirus 2 infection on placental histopathology is not well known. OBJECTIVE: To determine if any significant placental histopathologic changes occur after the diagnosis of severe acute respiratory syndrome coronavirus 2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulersen, Moti, Prasannan, Lakha, Tam Tam, Hima, Metz, Christine N., Rochelson, Burton, Meirowitz, Natalie, Shan, Weiwei, Edelman, Morris, Millington, Karmaine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428686/
https://www.ncbi.nlm.nih.gov/pubmed/32838277
http://dx.doi.org/10.1016/j.ajogmf.2020.100211
_version_ 1783571129945817088
author Gulersen, Moti
Prasannan, Lakha
Tam Tam, Hima
Metz, Christine N.
Rochelson, Burton
Meirowitz, Natalie
Shan, Weiwei
Edelman, Morris
Millington, Karmaine A.
author_facet Gulersen, Moti
Prasannan, Lakha
Tam Tam, Hima
Metz, Christine N.
Rochelson, Burton
Meirowitz, Natalie
Shan, Weiwei
Edelman, Morris
Millington, Karmaine A.
author_sort Gulersen, Moti
collection PubMed
description BACKGROUND: The impact of maternal severe acute respiratory syndrome coronavirus 2 infection on placental histopathology is not well known. OBJECTIVE: To determine if any significant placental histopathologic changes occur after the diagnosis of severe acute respiratory syndrome coronavirus 2 infection during pregnancy and whether these changes are correlated with the presence or absence of symptoms associated with the infection. STUDY DESIGN: A retrospective cohort study of women diagnosed as having severe acute respiratory syndrome coronavirus 2 infection who delivered at a single center from April 9, 2020 to April 27, 2020, and had placental specimens reviewed by the Department of Pathology. Women with singleton gestations and laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection were eligible for inclusion. Historical controls selected from a cohort of women who delivered 6 months before the study period were matched in a 1:1 fashion by weeks of gestation at delivery. Histopathologic characteristics were evaluated in each placenta, and the incidence of these findings was compared between placentas of those who received a diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection and historical controls, and between placentas from patients with or without typical symptoms related to the infection. Statistical analyses included the use of Wilcoxon rank-sum test and Fisher’s exact test for the comparison of categorical and continuous variables. Statistical significance was defined as a P value of <.05. RESULTS: A total of 50 placentas after the diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection and 50 historical controls were analyzed. Among the placentas from patients diagnosed with severe acute respiratory syndrome coronavirus 2 infection, 3 (6%) were preterm (33 3/7, 34 6/7, and 36 6/7 weeks of gestation), 16 (32%) were from patients with typical symptoms related to the infection, and 34 (68%) were from patients without typical symptoms related to the infection. All patients had received a diagnosis of severe acute respiratory syndrome coronavirus 2 infection in the third trimester. Decidual vasculopathy was not visualized in any of the placentas from patients diagnosed as having severe acute respiratory syndrome coronavirus 2 infection. There was no statistically significant difference in placental histopathologic characteristics between the groups. Severe acute respiratory syndrome coronavirus 2 test results for all neonates at 24 hours of life were negative. CONCLUSION: Based on the results of this study, there are no significant placental histopathologic changes that occur after the diagnosis of severe acute respiratory syndrome coronavirus 2 infection in women during the third trimester of pregnancy compared with a gestational age–matched historical control group. Similar incidences of histopathologic findings were also discovered when comparing placentas from patients with severe acute respiratory syndrome coronavirus 2 infection with or without the presence of symptoms typically related to the infection.
format Online
Article
Text
id pubmed-7428686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74286862020-08-17 Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection Gulersen, Moti Prasannan, Lakha Tam Tam, Hima Metz, Christine N. Rochelson, Burton Meirowitz, Natalie Shan, Weiwei Edelman, Morris Millington, Karmaine A. Am J Obstet Gynecol MFM Original Research BACKGROUND: The impact of maternal severe acute respiratory syndrome coronavirus 2 infection on placental histopathology is not well known. OBJECTIVE: To determine if any significant placental histopathologic changes occur after the diagnosis of severe acute respiratory syndrome coronavirus 2 infection during pregnancy and whether these changes are correlated with the presence or absence of symptoms associated with the infection. STUDY DESIGN: A retrospective cohort study of women diagnosed as having severe acute respiratory syndrome coronavirus 2 infection who delivered at a single center from April 9, 2020 to April 27, 2020, and had placental specimens reviewed by the Department of Pathology. Women with singleton gestations and laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection were eligible for inclusion. Historical controls selected from a cohort of women who delivered 6 months before the study period were matched in a 1:1 fashion by weeks of gestation at delivery. Histopathologic characteristics were evaluated in each placenta, and the incidence of these findings was compared between placentas of those who received a diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection and historical controls, and between placentas from patients with or without typical symptoms related to the infection. Statistical analyses included the use of Wilcoxon rank-sum test and Fisher’s exact test for the comparison of categorical and continuous variables. Statistical significance was defined as a P value of <.05. RESULTS: A total of 50 placentas after the diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection and 50 historical controls were analyzed. Among the placentas from patients diagnosed with severe acute respiratory syndrome coronavirus 2 infection, 3 (6%) were preterm (33 3/7, 34 6/7, and 36 6/7 weeks of gestation), 16 (32%) were from patients with typical symptoms related to the infection, and 34 (68%) were from patients without typical symptoms related to the infection. All patients had received a diagnosis of severe acute respiratory syndrome coronavirus 2 infection in the third trimester. Decidual vasculopathy was not visualized in any of the placentas from patients diagnosed as having severe acute respiratory syndrome coronavirus 2 infection. There was no statistically significant difference in placental histopathologic characteristics between the groups. Severe acute respiratory syndrome coronavirus 2 test results for all neonates at 24 hours of life were negative. CONCLUSION: Based on the results of this study, there are no significant placental histopathologic changes that occur after the diagnosis of severe acute respiratory syndrome coronavirus 2 infection in women during the third trimester of pregnancy compared with a gestational age–matched historical control group. Similar incidences of histopathologic findings were also discovered when comparing placentas from patients with severe acute respiratory syndrome coronavirus 2 infection with or without the presence of symptoms typically related to the infection. Elsevier Inc. 2020-11 2020-08-15 /pmc/articles/PMC7428686/ /pubmed/32838277 http://dx.doi.org/10.1016/j.ajogmf.2020.100211 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research
Gulersen, Moti
Prasannan, Lakha
Tam Tam, Hima
Metz, Christine N.
Rochelson, Burton
Meirowitz, Natalie
Shan, Weiwei
Edelman, Morris
Millington, Karmaine A.
Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title_full Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title_fullStr Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title_full_unstemmed Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title_short Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
title_sort histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428686/
https://www.ncbi.nlm.nih.gov/pubmed/32838277
http://dx.doi.org/10.1016/j.ajogmf.2020.100211
work_keys_str_mv AT gulersenmoti histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT prasannanlakha histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT tamtamhima histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT metzchristinen histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT rochelsonburton histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT meirowitznatalie histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT shanweiwei histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT edelmanmorris histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection
AT millingtonkarmainea histopathologicevaluationofplacentasafterdiagnosisofmaternalsevereacuterespiratorysyndromecoronavirus2infection